Marcaine 0,25% Adrenaline

Bupivacaine hydrochloride with epinephrine, the active ingredient in Marcaine 0,25% Adrenaline, is a local anesthetic presented as a 0.25%/1:200,000 injectable solution for epidural, infiltration and intra‑articular use. It provides regional anesthesia for surgical procedures and analgesia during peri‑operative care.

GNH USA supplies Marcaine 0,25% Adrenaline as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Marcaine 0,25% Adrenaline is used for local anesthetic and analgesic purposes in various surgical and procedural settings.

Surgical procedures: provides local anesthesia to facilitate operative interventions. Epidural analgesia: delivers continuous pain relief during labor or postoperative period. Infiltration anesthesia: numbs targeted tissue for minor surgeries or diagnostic procedures. Intra‑articular anesthesia: anesthetizes joint spaces for arthroscopic procedures.

Adverse reactions to Marcaine 0,25% Adrenaline may vary in frequency and severity.

Common Side Effects: - Injection site pain: mild discomfort at the site of administration. - Transient hypotension: temporary drop in blood pressure. - Nausea: occasional feeling of sickness. - Tachycardia: mild increase in heart rate due to epinephrine.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm, potentially life‑threatening. - Seizures: central nervous system excitation from high local anesthetic levels. - Allergic reaction: urticaria, bronchospasm, or anaphylaxis. - Methemoglobinemia: rare blood disorder.

When using Marcaine 0,25% Adrenaline, clinicians should observe several safety measures.

Patient assessment: evaluate cardiovascular status before use. Dose limitation: avoid exceeding recommended maximum dose for bupivacaine. Epinephrine caution: use with care in patients with uncontrolled hypertension. Monitoring: observe for signs of CNS toxicity during and after administration. Contraindications: do not use in patients with known hypersensitivity to bupivacaine or epinephrine. Store at ambient temperature: keep in original container, protect from light and moisture.

Marcaine 0,25% Adrenaline can interact with other medicines; awareness of significant interactions helps prevent adverse events.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase bupivacaine toxicity. - Beta‑blockers (e.g., propranolol): can potentiate epinephrine‑induced cardiovascular effects. - MAO inhibitors: may enhance epinephrine actions.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise bupivacaine plasma levels. - Lithium: may increase risk of neurotoxicity. - General anesthetics (e.g., propofol): additive CNS depression.